|1.||Morrissey, Colm: 1 article (01/2015)|
|2.||Ekpin, Esther: 1 article (01/2015)|
|3.||Aguirre-Ghiso, Julio A: 1 article (01/2015)|
|4.||Bernstein, Emily: 1 article (01/2015)|
|5.||Maia, Alexandre Gaspar: 1 article (01/2015)|
|6.||George, Ajish: 1 article (01/2015)|
|7.||Lam, Hung-Ming: 1 article (01/2015)|
|8.||Bragado, Paloma: 1 article (01/2015)|
|9.||Bosch, Almudena: 1 article (01/2015)|
|10.||Farias, Eduardo F: 1 article (01/2015)|
07/01/2007 - "Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries."
04/01/2005 - "The expressions of RAR-beta1, chicken ovalbumin upstream promoter-transcription factor-I (COUP-TFI), COUP-TFII, and peroxisome proliferator-activated receptor-gamma (PPAR-gamma) mRNA were reduced, whereas epidermal growth factor receptor and cyclin D1 expressions were increased in tumor compared with in normal tissues. "
|2.||Prostatic Neoplasms (Prostate Cancer)
|3.||Deafness (Deaf Mutism)
05/01/2009 - "The 5q15 microdeletion completely removes the nuclear receptor NR2F1 (COUP-TFI) from the inverted chromosome 5. We propose haploinsufficiency of NR2F1 to be the cause of the patient's deafness and many of the other associated anomalies based on striking similarity with the Nr2f1 null mouse. "
|4.||Transitional Cell Carcinoma
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
|3.||Messenger RNA (mRNA)
|4.||Progesterone Receptors (Progesterone Receptor)
|5.||Epidermal Growth Factor Receptor (EGF Receptor)